Barth Quoted on M&A Demand, Outlook of Trump’s Tax Reform Proposition
July 24, 2017
BizTimes Milwaukee
Partner Steven Barth was quoted in a BizTimes Milwaukee article, “M&A Demand Continues to Outpace Supply: Proposed Tax Changes Could Further Heighten Activity,” covering the impact that President Trump’s proposed tax reform would have on the mergers and acquisitions landscape.
Barth explained that Trump’s proposed lower one-time tax on capital held offshore by U.S. corporations would mean that “[companies] can take their sweet time of bringing [cash] home. If it was something of a temporary tax holiday, the flow of money into the U.S. … has to be used by this company somehow.”
He also explained that the repatriation tax is “too speculative to have any impact. If it starts getting closer, if there was a bill that was passed by the House, for example, before it gets to the Senate, then it would start impacting the timing of deals.”
Barth explained that Trump’s proposed lower one-time tax on capital held offshore by U.S. corporations would mean that “[companies] can take their sweet time of bringing [cash] home. If it was something of a temporary tax holiday, the flow of money into the U.S. … has to be used by this company somehow.”
He also explained that the repatriation tax is “too speculative to have any impact. If it starts getting closer, if there was a bill that was passed by the House, for example, before it gets to the Senate, then it would start impacting the timing of deals.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.